Today is “D-Day” for President Trump, as he tries to “upstage” the incoming president, by hosting a lavish party…
He has one problem though…
No-one wants to go!
Maybe not even his daughter, who is said to be heading to the inauguration ceremony herself…
Some large movements in the Lithium space with charging times for EVs expected to go to less than 5-minutes!
That will be certainly be a game-changer.
Read here.
Across markets…
Australian shares are set to edge higher, boosted by positive sentiment from Wall Street.
ASX futures were 4 points to 6681 near 8am AEDT. The currency edged up 0.2 per cent.
In New York, all three major benchmarks were higher in late trade. The Dow was 118 points or 0.4 per cent; the S&P 500 was up 0.9 per cent; the Nasdaq advanced 1.5 per cent.
Bolstering sentiment were comments from Janet Yellen, Joe Biden's nominee to run the Treasury Department.
Among her comments in a Senate nomination hearing, Dr Yellen said she supported more stimulus to help the US economy recovery from the pandemic.
“More must be done,” Dr Yellen said. “Without further action, we risk a longer, more painful recession now — and long-term scarring of the economy later.”
Source: AFR
ASX cannabis stocks have gotten a boost from the rising tide of regulation in recent months.
But in a December interview with Stockhead, cannabis investor Mark Bernberg said the onus is still on ASX cannabis stocks to prove out viable business models.
So what comes next? We caught up this week with three cannabis companies to get the view on regulation from the company side.
For all three, their path to a viable business model is based on clinical backing for cannabis products.
It’s a pathway more commonly associated with biotech stocks, and requires the same investment philosophy; patience with the possibility of a big payoff.
We contrasted the CBD biotech model with more traditional cannabis cultivation companies, featuring comments from listed players Medlab (ASX:MDC) and Incannex Healthcare (ASX:IHX) as well as private company Entoura.
Sector: Consumer Discretionary
Year: 2019
Deal Type: Placement
Raise Amount: $2.2m
Price Change: $0.046 +2.22%
Sector: Consumer Discretionary
Year: 2018, 2019
Deal Type: Seed, Bridging and IPO
Raise Amount: $10m
Price Change: $0.16 +10.34%
Sector: Technology
Year: 2018
Deal Type: Seed and IPO
Raise Amount: $10m
Price Change: $0.064 -8.57%
Sector: Mining
Year: 2017
Deal Type: Seed & IPO
Raise Amount: $5m
Price Change: $0.20 -2.38%
Sector: Mining
Year: 2017
Deal Type: IPO & Placement
Raise Amount: $6m
Price Change: $0.052 +4.00%
Sector: Healthcare Equipment and Services
Year: 2016
Deal Type: IPO
Raise Amount: $8m
Price Change: $0.12 +14.29%
Sector: Materials
Year: 2016
Deal Type: IPO
Raise Amount: $9m
Price Change: $0.033 -2.94%
Sector: Biotechnology
Year: 2015, 2017, 2018
Deal Type: Placements & IPO
Raise Amount: $5m
Price Change: $2.41 -1.63%
Sector: Media an Entertainment
Year: 2016
Deal Type: Reverse Takeover
Raise Amount: $4m
Price Change: $0.043 -2.27%
Sector: Mining
Year: 2018, 2019, 2020
Deal Type: Placements & Rights Offer
Raise Amount: $1.5m
Price Change: $0.012 +20.00%
Sector: Discretionary
Year: 2020
Deal Type: Placement
Raise Amount: $1.3m
Price Change: $0.071 +4.41%
Sector: Gaming
Year: 2020
Deal Type: Placement
Raise Amount: $1.25m
Price Change: $0.12 -3.85%
Sector: Mining (Gold)
Year: 2020
Deal Type: Placement
Raise Amount: $982k
Sector: Mining (Gold/Silver)
Year: 2020
Deal Type: Placement
Raise Amount: $2.3m
Price Change: $0.012 -7.69%
Sector: Hemp & CBD
Year: 2020
Deal Type: Pre IPO
Raise Amount: $2.5m
Sector: Psychedelic assisted therapy
Year: 2020
Deal Type: Placement
Raise Amount: $2.5m
Price Change: CAD $0.12 -3.85%
Sector: Mining
Year: 2020
Deal Type: Placement
Raise Amount: $330k
Price Change: 0.049 -2.00%
If you would like more information on future Peak deals, please don’t hesitate to get in touch.
